Pharmacology/Toxicology Faculty
- Margaret Clagett-Dame, Ph.D.
- Therapeutic applications of vitamin A and vitamin D analogs; retinoids in embryonic and nervous system development.
- Arash Bashirullah, Ph.D.
- Molecular genetics of hormone action and developmental timing.
- Ron Burnette, Ph.D.
- Developing a molecular level mechanistic understanding of the delivery and stability of drugs by physical chemical characterization of guest-host interactions using computational chemistry and NMR.
- Lara Collier, Ph.D.
- Genetic approaches to identify genes involved in cancer initiation, progression, and therapy resistance.
-
Warren Heideman, Ph.D.
- Understanding the molecular mechanisms that regulate the cellular transition from quiescence to growth; identifying critical mechanisms regulating vertebrate development that are disrupted by environmental contaminants; creating strategies for the fermentative production of biofuels.
- Jeffrey Johnson, Ph.D.
- Signal transduction, transcriptional control of neuroprotective genes and neurotoxicity in Parkinson’s, Alzheimer’s, Huntington’s and neuromuscular disease.
- Paul C. Marker, Ph.D.
- Molecular basis of prostate development and prostate cancer progression: roles of cell-cell signaling pathways and use of mouse genetics to discover novel prostatic oncogenes and tumor suppressors.
- William Mellon, Ph.D.
- Biochemical pharmacology of hormones. Mechanosensitive pathways of cellular function.
- Steven G. Oakes, Ph.D.
- Patient care and medication trends— southern Wisconsin population.
- Richard Peterson, Ph.D.
- Reproductive and developmental toxicity of dioxin and nanomaterials in zebrafish and mouse models.
Affiliate Faculty
- Ralph Albrecht, Ph.D.
- Use of inductively heated, antibody targeted, core-shell nanoparticles for selective removal of targeted cells in vitro and in vivo. Development of high resolution nanoparticle labeling systems for correlative microscopy.
- Adnan Elfarra
- Bioactivation of drugs, industrial chemicals, and environmental toxicants; biochemical basis for target organ selectivity; biomarkers of exposure and effect; structure and function of flavin-containing monooxygenases; glutathione-dependent prodrugs of anticancer drugs.
- Lauren Trepanier, Ph.D., D.V.M.
- Pharmacogenomics; metabolic basis of arylamine drug toxicity and arylamine carcinogenesis.